|
|
| March 29, 2014: Dr. Jennifer Robinson and Dr. C. Michael Gibson discuss: The Low-density Lipoprotein Cholesterol Assessment With PCSK9 M |
Dr. Jennifer Robinson and Dr. C. Michael Gibson discuss: The Low-density Lipoprotein
Cholesterol Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin
Therapy - 2 Trial: A Phase 3, Double-blind, Randomized, Placebo and Ezetimibe Controlled,
Multicenter Study to Evaluate Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in
Combination With Statin Therapy in Subjects With Primary Hypercholesterolemia and Mixed
Dyslipidemia.
TBD
[ Download video ] |
|
No comments have been submitted
|